Form 13-F position report

RVL PHARMACEUTICALS PLC ORDINA

Reported by MORGAN STANLEY

RVLPQ CUSIP G6S41R101 Manager CIK 0000895421

Reported 0 shares, down 32,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 21 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1475000
2022-03-31 2152000
2022-06-30 1660000
2022-09-30 2464000
2022-12-31 1228229
2023-03-31 1205616
2023-06-30 554096
2023-09-30 2771
2023-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for RVL PHARMACEUTICALS PLC ORDINA held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2023 Reduced 0 -32,000 (-100.0%) 0 $0 2024-02-13
Q3 2023 Reduced 32,000 -957,280 (-96.8%) < 0.01% $2,771 2023-11-15
Q2 2023 Reduced 989,280 -68,278 (-6.5%) < 0.01% $554,096 2023-08-14
Q1 2023 Reduced 1,057,558 -39,075 (-3.6%) < 0.01% $1,205,616 2023-05-15
Q4 2022 Reduced 1,096,633 -76,571 (-6.5%) < 0.01% $1,228,229 2023-02-14
Q3 2022 Reduced 1,173,204 -47,549 (-3.9%) < 0.01% $2,464,000 2022-11-14
Q2 2022 Reduced 1,220,753 -52,764 (-4.1%) < 0.01% $1,660,000 2022-08-15
Q1 2022 Reduced 1,273,517 -92,511 (-6.8%) < 0.01% $2,152,000 2022-05-13
Q4 2021 Reduced 1,366,028 -56,747 (-4.0%) < 0.01% $1,475,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

36 managers reported RVL PHARMACEUTICALS PLC ORDINA for Q4 2023.

Managers reporting RVL PHARMACEUTICALS PLC ORDINA in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
XTX Topco Ltd New 180,566 +180,566 < 0.01% $542 1 qtr
RAYMOND JAMES & ASSOCIATES New 23,696 +23,696 < 0.01% $71 1 qtr
BlackRock Inc Reduced 0 -225,721 0 $0 21 qtrs
FMR LLC Reduced 0 -500 0 $0 2 qtrs
JPMorgan Chase & Co Reduced 0 -3 0 $0 21 qtrs
Qube Research & Technologies Ltd Reduced 0 -50 0 $0 2 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -1,187 0 $0 14 qtrs
Williams Jones Wealth Management LLC Reduced 0 -10,000 0 $0 8 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 0 -12,078 0 $0 20 qtrs
LPL Financial LLC Reduced 0 -21,210 0 $0 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 13, 2024
Filing type
13F-HR
Position type
SHS

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.